472 related articles for article (PubMed ID: 33165869)
21. Development of nanoparticle adjuvants to potentiate the immune response against diphtheria toxoid.
Alshanqiti FM; Al-Masaudi SB; Al-Hejin AM; El-Baky NA; Redwan EM
Hum Antibodies; 2018 Feb; 26(2):75-85. PubMed ID: 29171990
[TBL] [Abstract][Full Text] [Related]
22. Stimuli-Responsive Polymeric Nanovaccines Toward Next-Generation Immunotherapy.
Mao L; Ma P; Luo X; Cheng H; Wang Z; Ye E; Loh XJ; Wu YL; Li Z
ACS Nano; 2023 Jun; 17(11):9826-9849. PubMed ID: 37207347
[TBL] [Abstract][Full Text] [Related]
23. Carrier-free subunit nanovaccine amplifies immune responses against tumors and viral infections.
Chen H; Li Y; Li L; Yang Z; Wen Z; Liu L; Liu H; Chen Y
Acta Biomater; 2023 Mar; 158():525-534. PubMed ID: 36572250
[TBL] [Abstract][Full Text] [Related]
24. Enhanced Antitumor Immune Responses via a Self-Assembled Carrier-Free Nanovaccine.
Liu D; Deng B; Liu Z; Ma B; Leng X; Kong D; Ji T; Liu L
Nano Lett; 2021 May; 21(9):3965-3973. PubMed ID: 33886338
[TBL] [Abstract][Full Text] [Related]
25. Chitosan-based Nanoparticles in Mucosal Vaccine Delivery.
Mehrabi M; Montazeri H; Mohamadpour Dounighi N; Rashti A; Vakili-Ghartavol R
Arch Razi Inst; 2018 Sep; 73(3):165-176. PubMed ID: 30280836
[TBL] [Abstract][Full Text] [Related]
26. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
[TBL] [Abstract][Full Text] [Related]
27. Nanoparticles and Vaccine Development.
Kheirollahpour M; Mehrabi M; Dounighi NM; Mohammadi M; Masoudi A
Pharm Nanotechnol; 2020; 8(1):6-21. PubMed ID: 31647394
[TBL] [Abstract][Full Text] [Related]
28. A MnAl double adjuvant nanovaccine to induce strong humoral and cellular immune responses.
Qiao N; Wang H; Xu Y; Chang Y; Xie M; Bai S; He C; Qin M; Zhong X; Jiang M; Guo Z; Du G; Zhang Z; Zhang Y; Sun X
J Control Release; 2023 Jun; 358():190-203. PubMed ID: 37116543
[TBL] [Abstract][Full Text] [Related]
29. Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2.
Park KS; Bazzill JD; Son S; Nam J; Shin SW; Ochyl LJ; Stuckey JA; Meagher JL; Chang L; Song J; Montefiori DC; LaBranche CC; Smith JL; Xu J; Moon JJ
J Control Release; 2021 Feb; 330():529-539. PubMed ID: 33358977
[TBL] [Abstract][Full Text] [Related]
30. Applications of Chitosan Derivatives as Adjuvant for Nanoparticles Based Vaccines.
Narayanan RR; Maanvizhi S
Infect Disord Drug Targets; 2023; 23(3):e220922209066. PubMed ID: 36154588
[TBL] [Abstract][Full Text] [Related]
31. Emerging peptide-based nanovaccines: From design synthesis to defense against cancer and infection.
Xu F; Yuan Y; Wang Y; Yin Q
Biomed Pharmacother; 2023 Feb; 158():114117. PubMed ID: 36528914
[TBL] [Abstract][Full Text] [Related]
32. Pathogen-Mimicking Polymeric Nanoparticles based on Dopamine Polymerization as Vaccines Adjuvants Induce Robust Humoral and Cellular Immune Responses.
Liu Q; Jia J; Yang T; Fan Q; Wang L; Ma G
Small; 2016 Apr; 12(13):1744-57. PubMed ID: 26849717
[TBL] [Abstract][Full Text] [Related]
33. Nanovaccines: A game changing approach in the fight against infectious diseases.
Priyanka ; Abusalah MAH; Chopra H; Sharma A; Mustafa SA; Choudhary OP; Sharma M; Dhawan M; Khosla R; Loshali A; Sundriyal A; Saini J
Biomed Pharmacother; 2023 Nov; 167():115597. PubMed ID: 37783148
[TBL] [Abstract][Full Text] [Related]
34. Polyethylenimine-coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant for H9N2 vaccine to improve immune responses in chickens compared to Alum and oil-based adjuvants.
Gu P; Wusiman A; Zhang Y; Cai G; Xu S; Zhu S; Liu Z; Hu Y; Liu J; Wang D
Vet Microbiol; 2020 Dec; 251():108894. PubMed ID: 33096470
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release.
Ilyinskii PO; Roy CJ; O'Neil CP; Browning EA; Pittet LA; Altreuter DH; Alexis F; Tonti E; Shi J; Basto PA; Iannacone M; Radovic-Moreno AF; Langer RS; Farokhzad OC; von Andrian UH; Johnston LP; Kishimoto TK
Vaccine; 2014 May; 32(24):2882-95. PubMed ID: 24593999
[TBL] [Abstract][Full Text] [Related]
36. Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed T
Tapia D; Sanchez-Villamil JI; Stevenson HL; Torres AG
mBio; 2021 Jun; 12(3):e0122721. PubMed ID: 34182777
[TBL] [Abstract][Full Text] [Related]
37. In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives.
Zeng Y; Zou F; Xia N; Li S
Expert Rev Vaccines; 2023; 22(1):681-695. PubMed ID: 37496496
[TBL] [Abstract][Full Text] [Related]
38. Immunomodulatory properties of vitamins, flavonoids and plant oils and their potential as vaccine adjuvants and delivery systems.
Vajdy M
Expert Opin Biol Ther; 2011 Nov; 11(11):1501-13. PubMed ID: 21955085
[TBL] [Abstract][Full Text] [Related]
39. [Development of vaccine adjuvants using polymeric nanoparticles and their potential applications for anti-HIV vaccine].
Akagi T; Baba M; Akashi M
Yakugaku Zasshi; 2007 Feb; 127(2):307-17. PubMed ID: 17268151
[TBL] [Abstract][Full Text] [Related]
40. Biomaterials for nanoparticle vaccine delivery systems.
Sahdev P; Ochyl LJ; Moon JJ
Pharm Res; 2014 Oct; 31(10):2563-82. PubMed ID: 24848341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
